BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23422352)

  • 1. Recombinant streptavidin-C3bot for delivery of proteins into macrophages.
    Christow H; Lillich M; Sold A; Fahrer J; Barth H
    Toxicon; 2013 Dec; 75():144-7. PubMed ID: 23422352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant fusion toxin based on enzymatic inactive C3bot1 selectively targets macrophages.
    Dmochewitz L; Förtsch C; Zwerger C; Vaeth M; Felder E; Huber-Lang M; Barth H
    PLoS One; 2013; 8(1):e54517. PubMed ID: 23349915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered clostridial C2 toxin as a novel delivery system for living mammalian cells.
    Fahrer J; Plunien R; Binder U; Langer T; Seliger H; Barth H
    Bioconjug Chem; 2010 Jan; 21(1):130-9. PubMed ID: 20030334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C2-streptavidin delivery system promotes the uptake of biotinylated molecules in macrophages and T-leukemia cells.
    Fahrer J; Rieger J; van Zandbergen G; Barth H
    Biol Chem; 2010 Nov; 391(11):1315-25. PubMed ID: 20868225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization.
    Wilde C; Vogelsgesang M; Aktories K
    Biochemistry; 2003 Aug; 42(32):9694-702. PubMed ID: 12911311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective and specific internalization of clostridial C3 ADP-ribosyltransferases into macrophages and monocytes.
    Fahrer J; Kuban J; Heine K; Rupps G; Kaiser E; Felder E; Benz R; Barth H
    Cell Microbiol; 2010 Feb; 12(2):233-47. PubMed ID: 19840027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptavidin-conjugated C3 protein mediates the delivery of mono-biotinylated RNAse A into macrophages.
    Lillich M; Chen X; Weil T; Barth H; Fahrer J
    Bioconjug Chem; 2012 Jul; 23(7):1426-36. PubMed ID: 22681511
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Fellermann M; Stemmer M; Noschka R; Wondany F; Fischer S; Michaelis J; Stenger S; Barth H
    Toxins (Basel); 2022 Oct; 14(10):. PubMed ID: 36287979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-inhibiting C2IN-C3 fusion toxin inhibits chemotactic recruitment of human monocytes ex vivo and in mice in vivo.
    Martin T; Möglich A; Felix I; Förtsch C; Rittlinger A; Palmer A; Denk S; Schneider J; Notbohm L; Vogel M; Geiger H; Paschke S; Huber-Lang M; Barth H
    Arch Toxicol; 2018 Jan; 92(1):323-336. PubMed ID: 28924833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation.
    Höltje M; Djalali S; Hofmann F; Münster-Wandowski A; Hendrix S; Boato F; Dreger SC; Grosse G; Henneberger C; Grantyn R; Just I; Ahnert-Hilger G
    FASEB J; 2009 Apr; 23(4):1115-26. PubMed ID: 19047066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
    Vogelsgesang M; Aktories K
    Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct biological activities of C3 and ADP-ribosyltransferase-deficient C3-E174Q.
    Rohrbeck A; Kolbe T; Hagemann S; Genth H; Just I
    FEBS J; 2012 Aug; 279(15):2657-71. PubMed ID: 22621765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of macrophage migration by C. botulinum exoenzyme C3.
    Rotsch J; Rohrbeck A; May M; Kolbe T; Hagemann S; Schelle I; Just I; Genth H; Huelsenbeck SC
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Sep; 385(9):883-90. PubMed ID: 22644106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin.
    Fahrer J; Funk J; Lillich M; Barth H
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):263-73. PubMed ID: 21136248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporally Controlled Release of Rho-Inhibiting C3 Toxin from a Protein-DNA Hybrid Hydrogel for Targeted Inhibition of Osteoclast Formation and Activity.
    Gačanin J; Kovtun A; Fischer S; Schwager V; Quambusch J; Kuan SL; Liu W; Boldt F; Li C; Yang Z; Liu D; Wu Y; Weil T; Barth H; Ignatius A
    Adv Healthc Mater; 2017 Nov; 6(21):. PubMed ID: 28758712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Supramolecular Approach toward Bioinspired PAMAM-Dendronized Fusion Toxins.
    Kuan SL; Förtsch C; Ng DY; Fischer S; Tokura Y; Liu W; Wu Y; Koynov K; Barth H; Weil T
    Macromol Biosci; 2016 Jun; 16(6):803-10. PubMed ID: 26833574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent assay of cell-permeable C3 transferase activity.
    Lasko D; McKerracher L
    Methods Enzymol; 2006; 406():512-20. PubMed ID: 16472683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uptake machinery of clostridial actin ADP-ribosylating toxins--a cell delivery system for fusion proteins and polypeptide drugs.
    Barth H; Blöcker D; Aktories K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):501-12. PubMed ID: 12444490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP-ribosylation of the rho/rac gene products by botulinum ADP-ribosyltransferase: identity of the enzyme and effects on protein and cell functions.
    Narumiya S; Morii N; Sekine A; Kozaki S
    J Physiol (Paris); 1990; 84(4):267-72. PubMed ID: 2127805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.